໒(• ŏᴗŏ•)७ try 1ClickPost.com paste text to share free

Dr. Altman on Neoadjuvant Chemotherapy in High-Grade Serous Carcinoma

Free Button: Daily News
Free Button: Daily News

  Info

Description

Alon Altman, MD, associate professor, Department of Obstertrics, Gynecology and Reproductive Sciences, University of Manitoba, discusses neoadjuvant chemotherapy for patients with high-grade serous carcinoma.

Tags

cancer oncology
  Email Video to Friends   Receive Emails for Similar Videos

Email:

  Repeat and Loop Video   Link to Video   Create Short URL  Publish Text About This Video   Share on Facebook, Twitter, and more
  See Recommended Videos For You
👕 Try MeTee.com: publish meme shirts in seconds and earn a commission forever

Related

  Dr. Barber on Neoadjuvant Chemotherapy in Ovarian Cancer   Dr. Nanus on Ongoing Studies in the Neoadjuvant Setting for RCC   Dr. Siefker-Radtke on FDA Approval of Frontline Atezolizumab in Bladder Cancer   Neoadjuvant Chemotherapy and Ovarian Cancer   Dr. Barber on Chemotherapy Versus Surgery for Ovarian Cancer   Which Breast Cancer Patients Need Lymph Nodes Removed? Mayo Clinic-Led Research Narrows It Down   Dr. Raman on Hematuria in Urothelial Carcinoma   Dr. Tripathy on Neoadjuvant Treatment Strategies in HER2+ Breast Cancer   The Role of Induction Chemotherapy in HNSCC   What Does Chemotherapy Actually Do To Your Body?   Dr. Petrylak on the KEYNOTE-045 Trial for Urothelial Carcinoma   Dr. Tolaney on Neoadjuvant HER2-Directed Therapy   Surgery, Radiotherapy, and Neoadjuvant Chemotherapy for Advanced STS   Chemotherapy Treatments - Types, Uses, Side Effects | Yashoda Hospitals | Telugu News | TV5 News   Dr. Holmes on Neoadjuvant Endocrine Therapy in Breast Cancer   Dr. Hoffman-Censits on Biomarker Development in Urothelial Carcinoma   Dr. Yee on Neoadjuvant Pertuzumab in HER2-Positive Breast Cancer   Squamous Cell Carcinoma - Mayo Clinic   Dr. Chagpar on Novel Agents for Neoadjuvant TNBC Treatment   Dr. Motzer on Nivolumab Versus Everolimus in Renal Call Carcinoma   Dr. Petrylak on Trial of Atezolizumab in Urothelial Carcinoma   Dr. Pal on RCS in Metastatic Urothelial Carcinoma   Dr. Jun on Results of Study in Cryptogenic Hepatocellular Carcinoma   Dr. Rini on Adjuvant Immunotherapy in Renal Cell Carcinoma   Dr. Oh on the Role of Chemotherapy in Prostate Cancer   Dr. Rai on Handicaps of Chemotherapy in CLL   Dr. Bunn on Combining Immunotherapy and Chemotherapy in Lung Cancer   Dr. Patel on Combination Chemotherapy and Immunotherapy in Lung Cancer   Dr. Finn on Studies of Pembrolizumab in Hepatocellular Carcinoma   Dr. Petrylak on Combinations with Pembrolizumab in Urothelial Carcinoma   Dr. Leonard on Ibrutinib Combined With Chemotherapy in Follicular Lymphoma   Dr. Siefker-Radtke on FDA Approval of Durvalumab in Bladder Cancer   Dr. O'Shaughnessy on Role of Chemotherapy in Future TNBC Treatment   Dr. Wei on Trial of Venetoclax Plus Chemotherapy in AML   Dr. Jun Discusses Cyptogenic Hepatocellular Carcinoma   Treatment Approaches to Resectable Melanoma   Former Grey's Anatomy Star Returning To Show   Dr. Ellis on Neoadjuvant Endocrine Therapy for Breast Cancer   Dr. Hurvitz on Neoadjuvant Therapy for HER2+ Breast Cancer   Dr. Altman on Gilteritinib in Patients With Relapsed/Refractory AML   Dr. Ahn on Neoadjuvant Treatments for Patients With Gastric Cancer   Dr. Hudis on Neoadjuvant Treatment of HER2-Positive Breast Cancer   Identifying Genes That Can Predict if Breast Cancer Drug Is Working - Mayo Clinic   Emerging Checkpoint Inhibitors for HNSCC   Dr. Apolo on Avelumab for Metastatic Urothelial Carcinoma   Lower Dose of Chemotherapy Effective for Liver Cancer Patients   Dr. Oh on AR-Targeted Therapy and Chemotherapy for CRPC   Can Diet Protect Against Kidney Cancer?   Dr. Plimack on Frontline Pembrolizumab for Urothelial Carcinoma   Dr. Hoffman-Censits on Challenges With Sequencing for Urothelial Carcinoma   Did Hugh Jackman Have Skin Cancer?   Dr. Minna on Chemotherapy and Radiation Therapy for Lung Cancer   Dr. Kuerer on Sentinel Node Clipping for Post-Chemotherapy Identification   Dr. Petrylak Discusses Trial of Atezolizumab in Urothelial Carcinoma   Dr. Lara Discusses Epacadostat in Renal Cell Carcinoma   Dr. Brufsky on Anastrozole Versus Tamoxifen in DCIS   Thyroid Cancer Causes, Treatment & Survival Rate | Health File | TV5 News   It's Not Swimsuit Season, It's Sun Protection Season   Cancer Drug Could Help Reduce Food Allergies, Study Finds   Hugh Jackman Treated Again for Skin Cancer on Nose   Dr. Venook Discusses the Role of Chemotherapy in Metastatic CRC   Dr. Oh Discusses the Role of Chemotherapy in Prostate Cancer   T-VEC Data in the Neoadjuvant Setting in Melanoma   HIPEC Treatment Offers Hope for Appendiceal Cancer - Mayo Clinic   Ragini Kudchadkar on Communication for Patients Without Internet Access   Medical trial could settle Stage 0 Breast Cancer treatment debate   Dr. Brufsky on CDK 4/6 Inihibitors in Neoadjuvant Breast Cancer Treatment   New study on chemotherapy   Dr. Apolo on Updated JAVELIN Results of Avelumab in Urothelial Carcinoma   Dr. Apolo on the Combination of Cabozantinib Plus Nivolumab in Urothelial Carcinoma   Dr. Cohen on Immunotherapy in Head and Neck Squamous Cell Carcinoma   Role of Lapatinib in HER2-Positive Breast Cancer   Dr. Choueiri on Impact of CABOSUN Results in Renal Cell Carcinoma   Surgical Options for Hepatocellular Carcinoma   Dr. Apolo on the Safety of Nivolumab Plus Cabozantinib in Urothelial Carcinoma

Popular Today